Tool Calling and Plugins for Rare Disease Clinical Trial Pre-screening

Rare disease data comes from diverse sources. These include Orphanet, the FDA Orphan Drug Database, clinical trial registries (e.g.

Data Characteristics in this Category

Rare disease data comes from diverse sources. These include Orphanet, the FDA Orphan Drug Database, clinical trial registries (e.g., ClinicalTrials.gov), gene sequencing databases, and patient registries. Data update frequencies vary. Orphan drug approvals and clinical trial registration information update more frequently, typically monthly or quarterly. Genomic data and patient phenotypic data may have longer update cycles.

Regarding document structure, most data is semi-structured or unstructured text. Examples include clinical trial protocol descriptions, disease diagnosis reports, and genetic testing reports. Fields and units are highly specific. For instance, gene mutation sites use c.123G>T, phenotype descriptions use HP:0000001 (Human Phenotype Ontology ID), disease codes use ORPHA:123 (Orphanet code), and drug dosages use mg/kg/day. These specialized identifiers and units require specific recognition and parsing in regular data processing.

Constraints from "Tool Calling and Plugins"

The multi-source and heterogeneous nature of rare disease data requires tool calling to flexibly adapt to various data interfaces and parsing logic. The presence of semi-structured text increases the complexity of information extraction. Plugins need advanced text parsing capabilities, such as Named Entity Recognition (NER) and relationship extraction.

Varying data update frequencies impact caching strategies and data synchronization mechanisms, ensuring the timeliness of call results. The existence of specific fields and units places higher demands on tool parameter validation and data conversion, preventing call failures due to format mismatches. For example, when querying clinical trials, precise matching of ORPHA codes or HP codes is essential; otherwise, relevant trials may not be retrieved. Additionally, much rare disease information is provided via proprietary database APIs, requiring plugins to handle complex authentication mechanisms and rate limits.

Configuration Settings

Configuration ItemRecommended ValueRationale
API_RATE_LIMIT_PER_MINUTE120 times per minuteMost rare disease database API limits; avoids 429 rate limit errors
PARSE_TIMEOUT_SECONDS60 secondsHandles complex text parsing and slow remote API responses
MAX_RETRIES_ON_FAILURE3 timesAddresses network fluctuations or temporary unavailability of external services
ENTITY_MATCH_THRESHOLD0.85Ensures accuracy in matching entities like rare disease names and gene loci
CACHE_EXPIRATION_HOURS24 hoursBalances data timeliness with API call costs
MAX_PAYLOAD_SIZE_MB10 MBAccommodates the size of structured report files returned by some databases

Three Common Mistakes

  • Receiving a 413 Request Entity Too Large error when calling an external database API. This usually indicates the request body sent is too large, possibly containing too many query conditions or complex structured data.
  • Plugin call duration significantly increases, far exceeding expectations. This may be due to excessive concurrent requests to an external API, hitting rate limits, leading to request queuing or throttling.
  • Key fields like rare disease names or gene mutations are empty or inaccurate in entity recognition or data extraction results. This occurs when the diverse naming conventions and specialized terminology of rare disease data are not fully considered, resulting in overly simplistic matching rules.

How to Verify Correct Configuration

  • Execute a series of queries with different ORPHA codes and HP codes. Verify that tool calls accurately return relevant clinical trial information.
  • Check log output. Confirm that no external service errors, such as 429 Too Many Requests or 503 Service Unavailable, occur during continuous high-frequency calls.
  • Run the information extraction plugin on typical rare disease clinical trial documents. Compare the extracted gene loci, drug dosages, and other key fields against the original text. Ensure entity recognition accuracy meets the expected threshold.
  • Simulate network delays or temporary external service interruptions. Observe whether the tool calling retry mechanism functions correctly according to MAX_RETRIES_ON_FAILURE and ultimately returns the expected failure or success status.

The values provided are common starting points. They should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.